<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="995">
  <stage>Registered</stage>
  <submitdate>12/01/2006</submitdate>
  <approvaldate>13/01/2006</approvaldate>
  <actrnumber>ACTRN12606000021572</actrnumber>
  <trial_identification>
    <studytitle>30Plus Study</studytitle>
    <scientifictitle>The effect of 30Plus on Premenstrual Syndrome: a randomised controlled study</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Prementrual syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Menstruation and menopause</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The intervention group would be women randomised into a group that will receive the 30Plus and </interventions>
    <comparator>control group would include women randomised into a group that will receive the placebo/control treatment for 3 months.</comparator>
    <control>Placebo</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To exam the difference between the active and placebo treatments total 21-DASS scores</outcome>
      <timepoint>At each month of the treatment during 3 month period of the study</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To examine the impact of this treatment on measuring the DASS sub-scores and the physical symptoms of PMS.</outcome>
      <timepoint>At each month of the treatment  during 3 month period of the study.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Have at least one of these psychological and physical symptoms during the 5 days before menses: Psychology: Depression, angry outbursts, irritability, anxiety, confusion or social withdrawal.Physical: Breast tenderness, abdominal bloating, headache, swelling of extremities.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Usage of hormonal therapies such as hormone replacement therapy (HRT) or the oral contraceptive pill (OCP), Usage of herbals and vitamins known to have an effect on PMS, Severe depression.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Code on medication container</concealment>
    <sequence>Randomised by computer program</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>1/02/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>110</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Natural Health Products</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>no</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Associate Professor John Eden</name>
      <address>Sydney Menopause Centre
Royal Hospital for Women
Level 0
Barker Street
Randwick NSW 2031</address>
      <phone>+61 2 93826777</phone>
      <fax />
      <email>j.eden@unsw.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Jinzhu Liu</name>
      <address>Sydney Menopause Centre
Royal Hospital for Women
Level 0
Barker Street
Randwick NSW 2031</address>
      <phone>+61 2 93826702</phone>
      <fax />
      <email>jz.liu@unsw.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>